Award

Kahn honored for research, mentoring

She won FASEB's Excellence in Science Award
George Van Den Driessche
By George Van Den Driessche
April 1, 2019

Barbara Kahn is the recipient of the Federation of American Societies for Experimental Biology’s 2019 Excellence in Science Award.

Barbara Kahn
“It is an honor to receive this award on behalf of the talented postdoctoral fellows, students and junior faculty who have catalyzed the discoveries in my lab, and our collaborators who have expanded our scientific horizons. The inspiration and skills of this team deserve this award. As a physician-scientist, my vision is to leverage emerging technologies to better understand metabolism and discover new approaches to prevent and treat metabolic diseases.”

— BARBARA KAHN

FASEB is honoring Kahn, the George R. Minot endowed chair and professor of medicine at Harvard Medical School and vice chair for research strategy in the Beth Israel Deaconess Medical Center department of medicine, for her contributions to diabetes research and the scientific community. Kahn is a member of the National Academy of Sciences and the National Academy of Medicine and a fellow of the American Association for the Advancement of Science.

Gerald I. Shulman, a professor at Yale University, wrote in his nomination letter that Kahn “has made pioneering discoveries throughout the past 30 years that elucidate the molecular mechanisms underlying obesity, insulin resistance and type 2 diabetes, with a particular emphasis on the role of the adipocyte in regulating glucose homeostasis.”

In the 1990s, Kahn discovered that obese and diabetic people had downregulation of the major insulin-regulated glucose transporter protein, GLUT4, in fat cells, causing insulin resistance. This discovery fueled a research career studying insulin action and the pathogenesis of type 2 diabetes. Kahn’s work regarding the cellular and molecular effects of altered GLUT4 levels resulted in identification of novel mechanisms that cause insulin resistance and increase the risk of developing diabetes. In the early 2000s, her lab determined that the fat-secreted retinol binding protein 4, RBP4, is increased in adipose tissue and blood in obesity and type 2 diabetes in humans, and this causes insulin resistance by creating a pro-inflammatory state. In 2012, Kahn’s lab found that increasing GLUT4 protein expression induces carbohydrate-response element-binding protein (ChREBP) which regulates fatty acid synthesis. Kahn’s lab discovered ChREBP is necessary in adipocytes to maintain whole-body insulin sensitivity.

The insights gained from these studies led to the discovery of a new class of lipids called branched fatty acid hydroxy fatty acids, or FAHFAs. Insulin-resistant people have low biological concentrations of FAHFAs. If these lipids are restored to normal healthy levels in diabetic mice, insulin sensitivity improves. These lipids may provide a new therapeutic treatment for Type 2 diabetes.

Kahn’s contributions go beyond groundbreaking research. She has mentored 100 postdocs and students, and she has played a leadership role in mentoring programs that help junior faculty, especially underrepresented minorities and women, gain high-visibility positions in the research community.

As a physician–researcher, Kahn has served as a consultant for the National Diabetes Advisory Board at the National Institutes of Health and is on the Advisory Council for the National Institute of Diabetes, Digestive and Kidney Diseases. She has served on numerous American Diabetes Association committees and as an editor for several academic journals. Kahn is also a leader within the Beth Israel Deaconess Medical Center where she was chief of the Diabetes Unit and the Division of Endocrinology, Diabetes, and Metabolism. She also co-chairs the Unconscious Bias Awareness committee for the department’s Committee on the Advancement of Women.

Kahn will receive her award at the ASBMB annual meeting during the Experimental Biology 2019 conference in Orlando, where she will deliver an award lecture titled “Glucose transport, adipose biology and novel mechanisms for regulating systemic insulin sensitivity” at 8 a.m. April 8 in Valencia Ballroom A at the Orange County Convention Center.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition weekly.

Learn more
George Van Den Driessche
George Van Den Driessche

George Van Den Driessche is a Ph.D. student in chemistry at North Carolina State University. Follow him on Twitter.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in People

People highlights or most popular articles

Guiding grocery carts to shape healthy habits
Award

Guiding grocery carts to shape healthy habits

Nov. 21, 2024

Robert “Nate” Helsley will receive the Walter A. Shaw Young Investigator in Lipid Research Award at the 2025 ASBMB Annual Meeting, April 12–15 in Chicago.

Leading the charge for gender equity
Award

Leading the charge for gender equity

Nov. 19, 2024

Nicole Woitowich will receive the ASBMB Emerging Leadership Award at the 2025 ASBMB Annual meeting, April 12–15 in Chicago.

Honors for de la Fuente, Mittag and De La Cruz
Member News

Honors for de la Fuente, Mittag and De La Cruz

Nov. 18, 2024

César de la Fuente receives the American Society of Microbiology’s Award for Early Career Basic Research. Tanja Mittag and Enrique M. De La Cruz are named fellows by the Biophysical Society.

In memoriam: Horst Schulz
In Memoriam

In memoriam: Horst Schulz

Nov. 18, 2024

He was a professor emeritus at City College of New York and at the CUNY Graduate Center in Manhattan whose work concentrated on increasing our understanding of mitochondrial fatty acid metabolism and an ASBMB member since 1971.

Computational and biophysical approaches to disordered proteins
Award

Computational and biophysical approaches to disordered proteins

Nov. 14, 2024

Rohit Pappu will receive the 2025 DeLano Award for Computational Biosciences at the ASBMB Annual Meeting, April 12-15 in Chicago.

Join the pioneers of ferroptosis at cell death conference
In-person Conference

Join the pioneers of ferroptosis at cell death conference

Nov. 13, 2024

Meet Brent Stockwell, Xuejun Jiang and Jin Ye — the co-chairs of the ASBMB’s 2025 meeting on metabolic cross talk and biochemical homeostasis research.